Zobrazeno 1 - 10
of 37
pro vyhledávání: '"I. V. Logacheva"'
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 1 (2021)
Aim. To create a model for non-alcoholic fatty liver disease (NAFLD) development at the steatosis stage in visceral obesity in patients with coronary artery disease (CAD) and hypertension (HTN).Material and methods. The study included male patients w
Externí odkaz:
https://doaj.org/article/1e244d556b46467aa16b4e0bb1065e00
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 28, Iss 6, Pp 27-37 (2019)
Aim. In this research, we set out to study organic changes in the heart and blood vessels of obese men suffering from non-alcoholic fatty liver disease (NAFLD) combined with cardiac pathology in the metabolically unhealthy phenotype (MUHP). Another o
Externí odkaz:
https://doaj.org/article/a2d375e03fe1463c805323378485bf1d
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 4, Pp 40-46 (2017)
Aim. To assess structural geometric and functional disorders of the heart in males with coronary heart disease (CHD) comorbid with arterial hypertension (AH) and with visceral abdominal obesity, and to evaluate the grade of association of epicardial
Externí odkaz:
https://doaj.org/article/e7a87c97864441718dc38580ef061ed1
Autor:
I. V. Logacheva, S. P. Baranova, V. V. Safronova, Т. A. Ryazanova, D. S. Zajtsev, D. V. Timonin
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 12, Pp 75-83 (2016)
Aim. To evaluate the possibility for the novel scores implementation in everyday management by perindopril/amlodipine in arterial hypertension patients of high and very high risk.Material and methods. Totally, 30 patients included, with AH of high an
Externí odkaz:
https://doaj.org/article/9452217776444505b0ffd9267cd22569
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 2, Iss 4, Pp 4-11 (2016)
Aim. To study dynamics of the indices of heart rate variability (HRV) and heart remodeling in response on combined therapy with fosinopril and simvastatin in postmenopausal metabolic syndrome (MS). Material and methods. 95 women were dynamically exam
Externí odkaz:
https://doaj.org/article/89752b9a1d09430aabb254af92b27383
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 4, Pp 75-81 (2014)
Aim. To investigate the antihypertensive effectiveness of a fixed perindopril/ amlodipine combination (Prestans) and its effects on the visit-to-visit variability of blood pressure levels and quality of life (QoL) among in-patients with uncontrolled
Externí odkaz:
https://doaj.org/article/1fa2471c48b642ca8b053c8c90317f7f
Autor:
I. V. Logacheva, E. A. Gunicheva
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 1, Pp 98-103 (2013)
Aim. To assess the effect of graduated physical exercise and extended release indapamide on the main parameters of circadian blood pressure (BP) profile, hemodynamics, and endothelial function in adolescents with Stage I essential arterial hypertensi
Externí odkaz:
https://doaj.org/article/606a895e6fdf48f4aa65ca6e0149913c
Autor:
I. V. Logacheva, E. A. Gunicheva
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 10, Iss 2, Pp 6-12 (2011)
Aim. To study the dynamics of office blood pressure (BP) levels, autonomic balance, endothelial dysfunction, and vascular remodelling in adolescents with Stage I arterial hypertension (AH), treated with indapamide retard (IR). Material and methods. I
Externí odkaz:
https://doaj.org/article/f4140e603f6c4ff89895508564b40269
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 6, Pp 13-15 (2000)
We herewith present our experience of complex treatment with enalapril combined with б-tocopherol and endovascular laser blood radiation in 86 hypertensive patients with LVH. We have established complex therapy for a year to promote complete and ear
Externí odkaz:
https://doaj.org/article/80951c77a58148ac93fe91692eba5dc9
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 2, Iss 4, Pp 4-11 (2016)
Aim. To study dynamics of the indices of heart rate variability (HRV) and heart remodeling in response on combined therapy with fosinopril and simvastatin in postmenopausal metabolic syndrome (MS). Material and methods. 95 women were dynamically exam